Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis

Journal of Pediatrics

Volumn 129, Issue 3, 1996, Pages 432-439

  Antoniazzi, F ^a   Bertoldo, F ^a   Mottes, M ^a   Valli, M ^a   Sirpresi, S ^a   Zamboni, G ^a   Valentini, R ^a   Tato, L ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; HUMAN GROWTH HORMONE;

ARTICLE; BONE DENSITY; BONE METABOLISM; CHILD; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; FEMALE; GROWTH RATE; HORMONAL THERAPY; HUMAN; MALE; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030378373     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70077-X     Document Type: Article

References (38)

1. PH. Byers Osteogenesis imperfecta PM Royce B Steinmann Connective tissue and its heritable disorders. 1993 Wiley-Liss New York 317 350
2. DO Sillence A Senn DM. Danks Genetic heterogeneity in osteogenesis imperfecta J Med Genet 16 1979 101 116
3. MC Willing SP Deschenes DA Scott Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen Am J Hum Genet 55 1994 638 647
4. M Ernst GA. Rodan Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3 Endocrinology 127 1990 807 814
5. TL McCarthy M Centrella E. Canalis Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures Endocrinology 124 1989 301 309
6. JC Marini S Bordenick G Heavner The growth hormone and somatomedin axis in short children with osteogenesis imperfecta J Clin Endocrinol Metab 76 1993 251 256
7. M Valli R Tenni G. Cetta Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple helical domain of type I collagen Matrix 10 1990 200 205
8. M Mottes A Sangalli M Valli A base substitution at IVS-19 3’-end splice junction causes exon 20 skipping in proα2(I) collagen mRNA and produces mild osteogenesis imperfecta Hum Genet 93 1994 681 687
9. ML Stover D Primorac SC Liu MB McKinstry DW Rowe Defective splicing of mRNA from one COL1A1 allele of type I collagen in nondeforming (type I) osteogenesis imperfecta J Clin Invest 92 1993 1994 2002
10. EE. Bleck Nonoperative treatment of osteogenesis imperfecta: orthotic and mobility management Clin Orth Rel Res 159 1981 111 122
11. WW Greulich SI. Pyle Radiologic atlas of skeletal development of the hand and wrist 2nd ed 1959 Stanford University Press Stanford
12. DW Rowe JR Shapiro M Poirier S. Schlesinger Diminished type I collagen synthesis and reduced alpha 1(I) collagen mRNA in cultured fibroblasts from patients with dominantly inherited (type I) ostegenesis imperfecta J Clin Invest 76 1985 604 611
13. JM Hock M Centrella E. Canalis Insulin-like growth factor I has independent effects on bone matrix formation and cell replication Endocrinology 122 1988 254 260
14. JE Wergedal S Mohan M Lundy DJ. Baylink Skeletal growth factor and other factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells J Bone Miner Res 5 1990 179 186
15. JC. Marini Osteogenesis imperfecta: comprehensive management Adv Pediatr 35 1988 391 426
16. U Vetter B Pontz E Zauner RE Brenner J. Spranger Osteogenesis imperfecta: a clinical study of the first ten years of life Calcif Tissue Int 50 1992 36 41
17. MWJ Davie MJ. Haddaway Bone mineral content and density in healthy subjects and in osteogenesis imperfecta Arch Dis Child 70 1994 331 334
18. DR Carter ML Bouxsein R. Marcus New approaches for interpreting projected bone densitometric data J Bone Miner Res 7 1992 137 145
19. OG Isakkson A Lindahl A Nilsson J. Isgaard Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth Endocr Rev 8 1987 426 438
20. JM Kaufman P Taelman A Vermeulen M. Vandeweghe Bone mineral status in growth hormone deficient males with isolated and multiple pituitary deficiencies of childhood onset J Clin Endocrinol Metab 74 1992 119 123
21. G Zamboni F Antoniazzi G Radetti C Musumeci L Tatò Effects of two different regimens of recombinant human growth hormone therapy on bone mineral density of patients with growth hormone deficiency J Pediatr 119 1991 483 485
22. G Saggese GI Baroncelli S Bertelloni L Cinquanta G. DiNero Effects of long-term treatment with growth hormone in bone and mineral development in children with growth hormone deficiency J Pediatr 122 1993 37 45
23. D Rudman AG Feller HS Nagraj Effects of human growth homone in men over 60 years old N Engl J Med 323 1990 1 6
24. GK Neely R Marcus RG Rosenfeld LK. Bachrach Turner syndrome adolescents receiving growth hormone are not osteopenic J Clin Endocrinol Metab 76 1993 861 866
25. F Antoniazzi F Bertoldo S Sirpresi R Valentini M Mottes M Valli L Tatò Growth hormone (hGH) treatment in type I osteogenesis imperfecta [abstract]. Proceedings of the 33rd Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), Maastricht, June 22-25, 1994 Horm Res 41 2-4 1994 147
26. A Chines A Boniface W McAlister M. Whyte Hypercalciuria in osteogenesis imperfecta: a follow-up study to assess renal effects Bone 16 1995 333 339
27. R Baron JM Gertner R Lang A. Vignery Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda Pediatr Res 17 1983 204 207
28. RE Brenner U Vetter AM Bollen M Mörike DR Eyre Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta J Bone Miner Res 9 1994 993 997
29. M Vandeweghe P Taelman JM. Kaufman Short- and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone deficient males Clin Endocrinol (Oxf) 39 1993 409 415
30. R. Bouillon Growth hormone and bone Horm Res 36 Suppl 1991 49 55
31. HP Kruse F. Kuhlencorrdt On an attempt to treat primary and secondary osteoporosis with human growth hormone Horm Metab Res 7 1975 488 491
32. S Castells S Yasumura MA Fusi C Colbert RS Bachtell S. Smith Plasma osteocalcin levels in patients with osteogenesis imperfecta J Pediatr 109 1986 88 91
33. RE Brenner B Schiller U Vetter J Ittner WM. Teller Serum concentrations of procollagen I C-terminal propeptide, osteocalcin and insulin-like growth factor-I in patients with nonlethal osteogenesis imperfecta Acta Paediatr 82 1993 764 767
34. H. Rico Osteocalcin levels in patients with osteogenesis imperfecta [letter] J Pediatr 111 1987 634
35. 3 and growth hormone therapy on serum osteocalcin levels in children with growth hormone deficiency Bone [Bone and Mineral 21 1993 151 156
36. KI. Kivirikko Urinary excretion of hydroxyproline in health and disease DA Hall DS Jackson International review of connective tissue research vol 5 1970 Academic Press New York 93 163
37. A Schlemmer JS Johansen SA Pedersen JO Jorgensen C Hassager C Christiansen The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults Clin Endocrinol 35 1991 471 476
38. AM. Parfitt The three organizational levels of bone remodeling: implications for the interpretation of biochemical markers and the mechanism of bone loss C Christiansen K Overgaard Osteoporosis. Proceedings of the Third International Symposium 1990 Osteopress Aps Copenaghen 429 434